Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
The SURMOUNT-5 head-to-head trial against Wegovy, published in 2025, demonstrated superior weight loss for tirzepatide
Improvements were seen in pain, bloating, and diarrhea, while constipation and satiety symptoms did not change significantly
Orlistat, liraglutide and tirzepatide, but not semaglutide, were associated with a significant reduction of incident diabetes
Pricing for telehealth competitors and FDA-approved branded medications referenced in this article is based on each provider's published rates as of April 2026
US$ 21.75
US$ 28.28
US$ 21.28
US$ 23.50
US$ 21.52
US$ 20.97
US$ 26.26
